All News #Library
Biotech
Kinevant`s Results from Namilumab Ph 2 in Pulmonary Sarcoidosis
03 Dec 2024 //
GLOBENEWSWIRE
Roivant, Kinevant Complete Namilumab RESOLVE-Lung Phase 2 Enrollment
25 Apr 2024 //
BUSINESSWIRE

Market Place
Sourcing Support